share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K:诺和诺德-股票回购计划
美股SEC公告 ·  09/09 11:10
Moomoo AI 已提取核心信息
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated this program on August 7, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. From August 26 to August 30, 2024, Novo Nordisk repurchased a total of 204,000 B shares at an average price of DKK 910.88, amounting to a transaction value of DKK 185,845,531. This brings the accumulated repurchases under the program to 744,187 B shares for a total cost of DKK 671,844,599. As of August 30, the company owns 13,139,944 B shares as treasury shares, which is 0.3% of the share capital. The total number of A and B shares, including treasury shares, is 4,465,000,000. Since the beginning of the repurchase plan on February 6, 2024, Novo Nordisk has bought back 11,811,313 B shares at an average price of DKK 880.47 per share, totaling DKK 10,399,550,649. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated this program on August 7, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. From August 26 to August 30, 2024, Novo Nordisk repurchased a total of 204,000 B shares at an average price of DKK 910.88, amounting to a transaction value of DKK 185,845,531. This brings the accumulated repurchases under the program to 744,187 B shares for a total cost of DKK 671,844,599. As of August 30, the company owns 13,139,944 B shares as treasury shares, which is 0.3% of the share capital. The total number of A and B shares, including treasury shares, is 4,465,000,000. Since the beginning of the repurchase plan on February 6, 2024, Novo Nordisk has bought back 11,811,313 B shares at an average price of DKK 880.47 per share, totaling DKK 10,399,550,649. Novo Nordisk's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球领先的医疗保健公司诺和诺德已经就其股票回购计划取得了进展。这家总部位于丹麦的公司自2024年8月7日启动了该计划,作为一项从2024年2月6日开始的为期12个月的DKk 200亿回购计划的一部分。从2024年8月26日至2024年8月30日,诺和诺德以平均价格DKk 910.88回购了2040000亿股,交易价值为DKk 185,845,531。这使得该计划下累计回购的股份达到7441870亿股,总成本为DKk 671,844,599。截至2024年8月30日,该公司持有131399440亿股作为财库股份,占股本的0.3%。包括财库股份在内的A股和B股总数为4,465,000,000。自2024年2月6日开始回购计划以来,诺和诺德以每股DKk 880.47的平均价格回购了118113130亿股,总计DKk 10,399,550,649。诺和诺德的股票在纳斯达克哥本哈根交易所上交易,并在纽约证券交易所上交易其ADR股。
全球领先的医疗保健公司诺和诺德已经就其股票回购计划取得了进展。这家总部位于丹麦的公司自2024年8月7日启动了该计划,作为一项从2024年2月6日开始的为期12个月的DKk 200亿回购计划的一部分。从2024年8月26日至2024年8月30日,诺和诺德以平均价格DKk 910.88回购了2040000亿股,交易价值为DKk 185,845,531。这使得该计划下累计回购的股份达到7441870亿股,总成本为DKk 671,844,599。截至2024年8月30日,该公司持有131399440亿股作为财库股份,占股本的0.3%。包括财库股份在内的A股和B股总数为4,465,000,000。自2024年2月6日开始回购计划以来,诺和诺德以每股DKk 880.47的平均价格回购了118113130亿股,总计DKk 10,399,550,649。诺和诺德的股票在纳斯达克哥本哈根交易所上交易,并在纽约证券交易所上交易其ADR股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息